Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

NCT04740697 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

OTHER: Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.

Sponsor

Institut Claudius Regaud